PathoQuest Secures 8 Million Euros in New Financing
PathoQuest, a genomic expert company dedicated to the microbiology testing market and a leader in clinical diagnostics and biologics testing applications, today announces the closing of an 8M euros financing series. The funding includes a venture loan from Norgine Ventures, financing from historical investors Kurma Partners, Idinvest Partners and strategic partner, Charles River Labs and a new venture investor, investiere. The financing also includes 427K euros in non-dilutive funding from the French Public Program Investissement d’Avenir (PIA3) - concours Innovation i-Nov which is dedicated to bioproduction.
“We are excited to make this investment in PathoQuest since they represent an exciting healthcare company that delivers novel solutions addressing challenges faced by biopharmaceutical companies in their quest to deliver safer, better treatments to patients,” stated Chris Gay-Crosier, Head International Investments at investiere. “ PathoQuest’s expertise has also enabled the company to broaden the application of next-generation sequencing (NGS) into clinical microbiology through the development of iDTECT™ Dx Blood, a promising new test designed to assist clinicians with their efforts to implement effective antimicrobial stewardship initiatives.”
“We are pleased to complete this financing round since it will permit the company to further establish our position as a leader in the application of NGS to microbiologic testing,” commented Jean-Francois Brepson, PathoQuest’s CEO. “This financing is a direct result of the company’s efforts to date, including the rapid expansion of our Biologics Genomic Services business and the advancement of efforts with iDTECT Blood in a clinical setting.”
International Technology and Life Sciences investment firm Fraser Finance ( fraserfinance.com) acted as exclusive financial advisor to PathoQuest for this transaction. Willy Mathot Avocat ( willymathot-avocat.com) acted as legal advisor to PathoQuest.
PathoQuest, a spin out of Institut Pasteur, is a life sciences company offering a game changing metagenomics approach to improving pathogen detection in biological samples. PathoQuest’s technology combines a Next-Generation Sequencing (NGS) platform and a proprietary sample preparation process which is applicable to several types of samples with a proprietary pathogen genome sequence database and automated analysis pipeline. The company’s solution provides microbiologists and clinicians with a comprehensive analysis covering all known clinically relevant human pathogens. PathoQuest has developed iDTECT™ Blood, the first and only CE IVD metagenomic test for clinical infectious disease diagnosis.
Based on the company’s technological platform, PathoQuest also offers biopharmaceutical companies a disruptive approach to secure production of biologics like vaccines, recombinant proteins, cell and gene therapies. PathoQuest’s Biological Genomic Services are currently being utilized by a growing number of major biopharma companies and clinical stage biotech companies. For more information visit www.pathoquest.com.
About Charles River
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.
Idinvest Partners is a leading European mid-market private equity firm. With €8bn under management, the firm has developed several areas of expertise including innovative startup venture capital transactions; mid-market private debt, i.e. single-tranche, senior and subordinated debt; primary and secondary investment and private equity advisory services. Founded in 1997, Idinvest Partners used to belong to the Allianz Group until 2010, when it branched out as an independent firm. In January 2018, Idinvest Partners became a subsidiary of Eurazeo, a leading global investment company, with a diversified portfolio of €17bn in assets under management, including approximately €11bn from investment partners, invested in over 350 companies. www.idinvest.com
investiere is the leading European startup investment platform for qualified and institutional investors. Our investment professionals screen thousands of companies and present the best investment opportunities on our digital platform after a rigorous due diligence process. investiere focuses on European high-tech startups. The investiere community consists of more than 3'600 qualified private investors, family offices and pension funds. Furthermore, numerous Swiss corporates rely on investiere's VC expertise to screen, select and invest in promising startups (clients include Swiss Post, u-blox, a leading Swiss health insurer, as well as a publishing house). With CHF 30 million invested in 2018, investiere is Switzerland’s most active startup investor. Zürcher Kantonalbank, the third-largest bank in Switzerland, is a minority shareholder of investiere. To join our international and growing investor community, visit www.investiere.ch.
About Kurma Partners
Founded in July 2009, Kurma Partners is a key European player in the financing of innovation in healthcare and biotechnology, from pre-creation to growth capital, notably through Kurma Biofund I through III and Kurma Diagnostics, as well as via strategic partnerships with prestigious European research and medical institutions. www.kurmapartners.com
About Norgine Ventures
Norgine, a leading European specialist pharmaceutical company that has been bringing transformative medicines to patients for over a century, established Norgine Ventures as a complementary business in 2012. Norgine Ventures supports innovative healthcare companies through the provision of debt-like financing in Europe and the US. For more information, please visit www.norgineventures.com.
+33 (0) 170 821 790
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NXP Semiconductors Expands Global Use of the Workiva Platform to Gain Efficiencies and Reduce Risk27.2.2020 10:00:00 EET | Press release
Workiva (NYSE:WK), provider of the world’s leading connected reporting and compliance platform, today announces that Netherlands-based NXP Semiconductors uses the Workiva platform to streamline filings with the U.S. Securities and Exchange Commission and to modernize its Sarbanes Oxley Act (SOX) processes. “We use the Workiva platform to save time in our reporting processes and create efficiencies across our entire finance organization,” said Bryan Moiles, Assistant Corporate Controller at NXP. “We have teams in the Netherlands and the U.S., and the Workiva platform is the only solution that allows me to run a 24-hour clock where I don't have to worry about version control.” With Workiva, Moiles and his team create automatic updates, track every change and seamlessly collaborate with colleagues around the world in real time to create trusted reports and regulatory filings. “The Workiva platform is our one source of truth for all our reports,” said Moiles. “Because everything is linked
DSB to Divest Spare Part Workshops27.2.2020 10:00:00 EET | Press release
Due to structural changes DSB is investigating the market with a view to divesting the activities at the workshops which deliver and maintain spare parts for the trains. Until 2030, Fremtidens Tog (Future Trains) will gradually replace the train sets that DSB is currently operating. This implies that DSB will no longer have the same need to operate its own spare part workshops. Besides, DSB’s coming generation of electric train sets, Fremtidens Tog, are to be maintained by the train supplier and not by DSB, meaning that DSB will have fewer options to redeploy staff from the spare part workshops. Therefore DSB is now transferring the areas of Supply, Logistics & Refurbishment to an independent company to investigate a divestment to a private third party in collaboration with SEB Corporate Finance. As part of this potential transaction, DSB will enter into an agreement with the divested company for delivery and maintenance of spare parts until 2024 with an extension option. As an indepen
Schlumberger Announces First-Quarter 2020 Results Conference Call27.2.2020 01:01:00 EET | Press release
Schlumberger Limited (NYSE: SLB) will hold a conference call on April 17, 2020 to discuss the results for the first quarter ending March 31, 2020. The conference call is scheduled to begin at 8:30 a.m. US Eastern time and a press release regarding the results will be issued at 7:00 a.m. US Eastern time. To access the conference call, listeners should contact the Conference Call Operator at +1 (844) 721-7241 within North America or +1 (409) 207-6955 outside of North America approximately 10 minutes prior to the start of the call and the access code is 4013483. A webcast of the conference call will be broadcast simultaneously at www.slb.com/irwebcast on a listen-only basis. Listeners should log in 15 minutes prior to the start of the call to test their browsers and register for the webcast. Following the end of the conference call, a replay will be available at www.slb.com/irwebcast until May 17, 2020, and can be accessed by dialing +1 (866) 207-1041 within North America or +1 (402) 970-
Energous Secures Industry-first Regulatory Approval for its Revolutionary WattUp Wireless Charging Technology in Japan27.2.2020 00:02:00 EET | Press release
Today Energous Corporation (Nasdaq: WATT), the developer of WattUp®, a revolutionary wireless charging 2.0 technology, announced that it has received regulatory approval for its WattUp Near Field wireless charging technology in Japan. “Having secured regulatory approval for our WattUp wireless charging technology in Japan is a major regulatory milestone for Energous,” said Stephen R. Rizzone, president and CEO of Energous Corporation. “This opens the door to sell WattUp-enabled products in a major Asia Pacific market.” Energous’ WattUp wireless charging technology underwent testing by independent, accredited test labs and was determined to be compliant with all regulatory requirements in Japan. “WattUp approval in Japan is a big step forward for Energous and our customers, while increasing momentum to achieve global market access,” said Dan Lawless, vice president of regulatory affairs at Energous Corporation. “We are establishing a regulatory framework for the large-scale deployment o
British Firm BitePRO Claim Mental Health Care Professionals Are At Risk Of Being Bitten26.2.2020 20:12:00 EET | Press release
According to British firm BitePRO, mental health care and special educational needs professionals are at increased risk of being bitten by patients or pupils. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200226005697/en/ Healthcare nurse wearing BitePRO® Bite Resistant Clothing (Photo: Business Wire) Many nurses, care workers and teachers retire on medical grounds. They walk away from the profession they were once extremely passionate about, partly because medical experts have been able to identify that they suffer from real trauma and severe stress. Others, like Minnesota based Special Education Assistant Erin Gonzales are keen to continue and state: “I work at a school where human bites are a daily occurrence, but I work with kids with special needs. But honestly, I wouldn’t trade it for the world.” Oklahoma based Psychiatric Nurse Practitioner Miranda Hagan shares her desire and refuses to give up: “I have permanent sca
Strengthening Position in the Smart Energy Space, Trilliant Acquires Quadlogic Multi-Tenant Panel and ANSI Socket-Based Metering Solutions26.2.2020 17:30:00 EET | Press release
Trilliant Networks, a global provider of leading Smart Grid and Smart City solutions, announced that they have acquired rights to Quadlogic’s multi-tenant panel and ANSI-based metering for Canada and international markets. This acquisition enables Trilliant to augment their leadership position in providing custom-tailored and turn-key metering services and solutions to the Canadian and international marketplace. Multi-tenant metering measures the electricity use of individual suites in multi-occupant buildings including condos and facilitates accountability for each suite’s own costs. A benefit of converting from bulk or master-metered service to submetering services is that electricity consumption is measured at precise intervals with the ability to capture time-of-use data. “Quadlogic’s technology is the current industry standard metering platform for mixed use, commercial, and multi-residential applications, and is a perfect fit to support our growth strategy” said Steven Lupo, mana
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom